Navigation Links
Salix Pharmaceuticals Donates $500,000 To ASGE's IT&T Capital Campaign To Build A New State-of-the-Art GI Training Center
Date:12/4/2012

OAK BROOK, Ill., Dec. 4, 2012 /PRNewswire-USNewswire/ -- The American Society for Gastrointestinal Endoscopy (ASGE) Foundation has received a donation of $500,000 from Salix Pharmaceuticals to ASGE's  IT&T Capital Campaign, a fundraising project to construct a new facility that will provide cutting-edge technology and training capabilities to significantly optimize current educational opportunities. The donation will be made over five years.

"We are grateful to Salix Pharmaceuticals for this very generous donation. Their pledge is an investment in the future of gastrointestinal endoscopy," said Thomas M. Deas, Jr., MD, MMM, FASGE, president, American Society for Gastrointestinal Endoscopy. "'The Global Home for Endoscopy' will be a facility offering state-of-the-art gastrointestinal endoscopy training in an interactive environment to address the future needs of physicians, the endoscopy team and patients. It will attract physicians from around the world in addition to reaching physicians where they live through broadcast transmissions of educational courses from the IT&T center."

ASGE has been providing learning opportunities at its current Institute for Training & Technology (IT&T) in Oak Brook, Ill. The new facility will be situated on a 3.5-acre plot in Chicago's Downers Grove suburb, close to both O'Hare and Midway airports, and will serve as the global home of endoscopy, offering a full range of medical training and continuing medical education (CME).

"We applaud the American Society for Gastrointestinal Endoscopy's leadership in advancing the diagnosis and treatment of gastrointestinal disease," stated Carolyn Logan, president and chief executive officer, Salix Pharmaceuticals.  "Salix is committed to providing gastrointestinal-focused solutions for patients and healthcare providers, and with that commitment in mind, we are pleased to support this ASGE initiative which will expand educational opportunities for endoscopists."

The new facility will offer:

  • State-of-the-art laboratory facilities that will house up to 16 hands-on stations to provide training simulations using the latest equipment and technologies in endoscopy; built-in flexibility to accommodate equipment and models for hands-on training and simulation in other specialties
  • Advanced training models and simulators
  • A 100-seat auditorium with an audience-response system
  • In-house real-time DVD recording of courses and rapid duplication capabilities
  • Additional conference space and breakout rooms
  • The capability to broadcast and receive live transmissions anywhere in the world, including endoscopic instruction and demonstration of techniques as well as didactic lectures on research and educational findings
  • The potential to provide real-time or recorded access online to IT&T hands-on and didactic courses via video streaming technology
  • The ability for domestic and international faculty to participate in courses on site or via satellite to teach cutting-edge techniques live to anyone, anywhere in the world
  • A resource for international members to extend training while in the U.S. attending Digestive Disease Week® or other meetings, allowing them to learn and practice techniques that are not standard in their regions of the world
  • Rentable lab, auditorium, banquet and conference rooms
  • The facility is designed to accommodate training by many medical specialties and is available for use by other organizations interested in renting space

ASGE IT&T Capital Campaign
ASGE's IT&T Capital Campaign is a fundraising project through the ASGE Foundation to construct the new facility that will provide cutting-edge technology and training capabilities to significantly optimize current educational opportunities. ASGE and the ASGE Foundation promote ongoing research in gastrointestinal endoscopy and its applications to disease management and prevention to ultimately improve the quality of endoscopy delivered to patients. The ASGE Foundation also funds programs designed to improve physician training and foster career development as well as supports important educational initiatives aimed at explaining the role of endoscopy in digestive health to the public. The IT&T Capital Campaign has raised funds from ASGE members and corporate partners, and as of November 2012, the campaign has surpassed its $6 million goal.

To learn more about the IT&T Capital Campaign, visit www.asge.org/ITTCampaign.

About the American Society for Gastrointestinal Endoscopy
Since its founding in 1941, the American Society for Gastrointestinal Endoscopy (ASGE) has been dedicated to advancing patient care and digestive health by promoting excellence and innovation in gastrointestinal endoscopy.  ASGE, with more than 12,000 members worldwide, promotes the highest standards for endoscopic training and practice, fosters endoscopic research, recognizes distinguished contributions to endoscopy, and is the foremost resource for endoscopic education.  Visit www.asge.org and www.screen4coloncancer.org for more information and to find a qualified doctor in your area.

About Salix Pharmaceuticals
Salix Pharmaceuticals, Ltd., headquartered in Raleigh, North Carolina, develops and markets prescription pharmaceutical products for the prevention and treatment of gastrointestinal diseases. Salix's strategy is to in-license late-stage or marketed proprietary therapeutic products, complete any required development and regulatory submission of these products, and market them through the Company's gastroenterology specialty sales and marketing team. 

About Endoscopy
Endoscopy is performed by specially-trained physicians called endoscopists using the most current technology to diagnose and treat diseases of the gastrointestinal tract. Using flexible, thin tubes called endoscopes, endoscopists are able to access the human digestive tract without incisions via natural orifices. Endoscopes are designed with high-intensity lighting and fitted with precision devices that allow viewing and treatment of the gastrointestinal system.

Media Contact: Anne Brownsey
(630) 570-5635
abrownsey@asge.org


'/>"/>
SOURCE American Society for Gastrointestinal Endoscopy
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Questcor Pharmaceuticals Accelerates Cash Dividend; Payment Date Set for December 21, 2012
2. Double-digit Growth Rate of the Pharmaceuticals Industry in Asia Pacific Boosts the API Market, Finds Frost & Sullivan
3. Cadence Pharmaceuticals to Host Analyst and Investor Day
4. Nobel Prize Winner Bruce Beutler joins Sound Pharmaceuticals
5. Valeant Pharmaceuticals Announces New Management Appointments
6. Arena Pharmaceuticals and Ildong Pharmaceutical Enter Into Co-Development and License Agreement for Temanogrel, a Novel Agent for Thrombotic Diseases
7. SHAREHOLDER ALERT: Morgan & Morgan announces an investigation of Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) and whether senior management and the board of directors violated fiduciary duties owed to Vertex shareholders.
8. Merrimack Pharmaceuticals To Present Phase I Data On MM-302 And Preclinical Data On Companion Diagnostics Both For The Treatment Of HER2-Positive Breast Cancer
9. Avanir Pharmaceuticals Pre-Announces Preliminary Fiscal 2012 Fourth Quarter Results And Provides Clinical Study Update
10. Unigene and Tarix Pharmaceuticals Enter Definitive Licensing Agreement for "Peptelligence-Engineered" TXA127
11. Actinium Pharmaceuticals Sponsors Webinar on Clinical Use of Alpha Immunotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... June 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as ... Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) ... Daylight Time). As previously announced on May ... definitive merger agreement under which Jazz Pharmaceuticals has commenced ...
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... -- Dehaier Medical Systems Ltd. (NASDAQ: DHRM ... sells medical devices and wearable sleep respiratory products in ... agreement with Hongyuan Supply Chain Management Co., Ltd. (hereinafter ... 2016, to develop Dehaier,s new Internet medical technology business. ... leverage Hongyuan Supply Chain,s sales platform to reach Dehaier,s ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a Media Slicing ... their videos a whole new perspective by using the title layers in ProSlice ... , ProSlice Levels contains over 30 Different presets to choose from. FCPX ...
(Date:6/26/2016)... ... June 26, 2016 , ... ... they have been diagnosed with endometriosis. These women need a treatment plan to ... a comprehensive approach that can help for preservation of fertility and ultimately achieving ...
(Date:6/25/2016)... Miami, FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton ... Plant City Observer , brings up a new, often overlooked aspect of head lice: ... The closing for fumigation is not a common occurrence, but a necessary one in the ...
(Date:6/25/2016)... ... , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors ... Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green ... hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train ...
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
Breaking Medicine News(10 mins):